• #EULAR2018 – Lenabasum Safe and Effective in Diffuse Scleroderma Patients, One-year Trial Data Show
  • Scleroderma, Pregnancies, and Finding Your Worth In Between
  • ‘Rare Impact Awards’ Dinner Marks Orphan Drug Act and NORD at 35
  • #ECRD2018 – EU Must Do More for Rare Disease Patients, Eurordis Leaders Say
  • Methotrexate Superior to Phototherapy in Childhood Localized Scleroderma, Study Finds
  • Study Offers New Insights to Help Improve Diagnosis, Care of Juvenile Scleroderma Patients
  • New Challenges, New Activities
  • Levels of Specific Cytokines Linked to Clinical Manifestations of Scleroderma, Study Reports
  • Lung Transplants in Scleroderma Patients As Safe, Effective As in Other Lung Disease Patients, Study Shows
  • How to Create a Skin Care Routine with Scleroderma
  • #ECRD2018 – Patient Access and Collaboration Focus of Eurordis Meeting May 10-12
  • Rituximab Shows Promise in Treatment of Diffuse Systemic Sclerosis, Study Finds